According to a Reuters report, Australia expects to receive its first batches of a potential Covid-19 vaccine in January, Australian Prime Minister Scott Morrison said on Monday, as the number of new daily infections in the country’s virus hotspot fell to a 10-week low. CLICK HERE TO READ FULL REPORT
Plc, the company's parent firm, is expected to release initial data on whether a vaccine can stop people from getting the virus on September 15. The drugmaker has pledged as many as 30 million doses to the UK by the end of the month.
Meanwhile, since August 18, 2020, the stock of Astrazeneca
Pharma has gained 35 per cent, after the company received import and market permission in Form CT-20 (Marketing Authorization) from the Drugs Controller General of India for Olaparib Film-Coated tablets 100 mg and 150 mg - additional indication. CLICK HERE FOR RELEASE